LONDON (Reuters) -British scientific instruments maker Spectris has agreed to a sweetened offer from U.S. private equity firm ...

The sweetened offer comes days after Advent improved its bid for Spectris, prompting the target to withdraw its ...

US private equity group’s offer nudges out rival bidder once again in race to acquire UK scientific instruments maker ...

Advent International has outbid KKR in a private equity bidding war for Spectris after the UK industrial group accepted its ...

KKR has agreed on a recommended increased cash offer for Spectris at an offer value of £41.75 per share. This values the entire issued and to be issued share capital of Spectris at around £4.2 billion ...

Spectris plc, which is the subject of a takeover by US private equity firm KKR, has secured an increased offer which values the listed industrial group at about £4.8bn.

British scientific instruments maker Spectris SXS.L has agreed to private equity firm Advent's sweetened takeover offer worth ...

The increased offer from KKR, which will be implemented through a court-sanctioned scheme of arrangement, represents a substantial premium of 104.9% to Spectris’ closing price of £20.38 on June 6, ...

OPEN The FTSE 100 was expected to open 35.1 points higher ahead of the bell on Tuesday after wrapping up the previous session 0.66% firmer at 9,128.30.

Advent International said it increased its takeover bid for precision-measurement company Spectris to 4.2 billion pounds ($5.55 billion).

Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease ...

Cognito Therapeutics today announced the presentation of new findings from a study of its non-invasive Spectris neuromodulation system.